Report Overview
Summary
Ascenta Therapeutics (Ascenta) is a biopharmaceutical company. The company discovers and develops medicines for the treatment of cancer. It manufactures novel, orally active, small molecule drugs that restore the natural potential for cancer cells to undergo cell death. Ascentas product includes AT-101, AT-406 and HDM2 Inhibitor. The companys AT-101 stimulates apoptosis in cancer cells by inhibiting multiple Bcl-2 family proteins. Its AT-406 promotes programmed cell death in tumor cells by blocking the activity of inhibitors of apoptosis proteins. The companys HDM2 inhibitor is a protein that regulates the activity of another component of the apoptotic pathway. It has strategic collaboration with Sanofi Aventis, Ascentage Pharma Group Corporation, and the Leukemia and Lymphoma Society. Ascenta Therapeutics is headquartered in Malvern, Pennsylvania, the US.
Ascenta Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table Of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Ascenta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 4
Ascenta Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
Ascenta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Ascenta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8
Ascenta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 9
Ascenta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Ascenta Therapeutics Secures US$1.8 Million In Venture Financing 10
Partnerships 12
Ascenta Therapeutics Enters Into Co-Development Agreement With The Leukemia & Lymphoma Society 12
Licensing Agreements 14
Debiopharm Enters Into Licensing Agreement With Ascenta Therapeutics For AT-406 14
Ascenta Therapeutics Enters Into Licensing Agreement With Ascentage Pharma For AT-101 And AT-406 16
Ascenta Therapeutics Enters Into Licensing Agreement With Ascentage Pharma 18
Ascenta Therapeutics Enters into Licensing Agreement with Sanofi 20
Ascenta Therapeutics, Inc. - Key Competitors 22
Key Employees 23
Locations And Subsidiaries 24
Head Office 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25
List Of Tables
Ascenta Therapeutics, Inc., Pharmaceuticals & Healthcare, Key Facts 1
Ascenta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Ascenta Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
Ascenta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Ascenta Therapeutics, Inc., Deals By Therapy Area, 2009 to YTD 2015 8
Ascenta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 9
Ascenta Therapeutics Secures US$1.8 Million In Venture Financing 10
Ascenta Therapeutics Enters Into Co-Development Agreement With The Leukemia & Lymphoma Society 12
Debiopharm Enters Into Licensing Agreement With Ascenta Therapeutics For AT-406 14
Ascenta Therapeutics Enters Into Licensing Agreement With Ascentage Pharma For AT-101 And AT-406 16
Ascenta Therapeutics Enters Into Licensing Agreement With Ascentage Pharma 18
Ascenta Therapeutics Enters into Licensing Agreement with Sanofi 20
Ascenta Therapeutics, Inc., Key Competitors 22
Ascenta Therapeutics, Inc., Key Employees 23
List Of Figures
Ascenta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 1
Ascenta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 1
Ascenta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 1
Ascenta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 1
Ascenta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Ascenta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 6
Ascenta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Ascenta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8